Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial
Fields of Study & Subjects
Psoriasis: Treatment and Pathogenesis
Lymphatic System and Diseases
Childhood Cancer Survivors' Quality of Life
Publication details
- Journal / source
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Volume
- 94
- Issue
- 6
- Pages
- 1777–1780
- Publication date
- 3 February 2026
- Language
- EN